222 related articles for article (PubMed ID: 2796388)
1. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
2. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
3. Colony formation by megakaryocyte progenitors in myelodysplatic syndromes.
Juvonen E; Partanen S; Knuutila S; Ruutu T
Eur J Haematol; 1989 Apr; 42(4):389-95. PubMed ID: 2721661
[TBL] [Abstract][Full Text] [Related]
4. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
6. [Culture of cells forming granulomonocytic colonies in bone marrow (GM-CFU) in myelodysplastic syndromes and their relation to hematological findings and FAB subtype].
García M; Sanz GF; Arriaga F; Pérez-Sirvent ML; Marty ML; Sanz MA
Sangre (Barc); 1991 Aug; 36(4):269-75. PubMed ID: 1776105
[TBL] [Abstract][Full Text] [Related]
7. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
8. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome.
Aoki I; Higashi K; Homori M; Chikazawa H; Ishikawa K
Am J Hematol; 1990 Sep; 35(1):6-12. PubMed ID: 2389770
[TBL] [Abstract][Full Text] [Related]
9. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
11. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
12. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
13. In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Carlo-Stella C; Cazzola M; Bernasconi P; Bergamaschi G; Dezza L; Pedrazzoli P; Rosti V; Tomaselli S; Zappone E
Haematologica; 1989; 74(2):181-6. PubMed ID: 2501171
[TBL] [Abstract][Full Text] [Related]
14. Increased peripheral stem cell pool in MDS: an indication of disease progression?
Vehmeyer K; Haase D; Alves F
Leuk Res; 2001 Nov; 25(11):955-9. PubMed ID: 11597730
[TBL] [Abstract][Full Text] [Related]
15. Three-lineage hemopoietic precursor cells and effectiveness of recombinant human erythropoietin in patients with myelodysplastic syndromes.
Fukushima Y; Kanno Y; Miura AB
Tohoku J Exp Med; 1992 Mar; 166(3):375-85. PubMed ID: 1585347
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
Piguet D; Schmidt PM; Delacrétaz F; Mermillod B
Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
18. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
[TBL] [Abstract][Full Text] [Related]
19. [Myelodysplastic syndromes--from FAB to WHO classification].
Kotlarek-Haus S; Haus O
Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
[No Abstract] [Full Text] [Related]
20. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
